The Evolution of Triamcinolone Acetonide Therapeutic Use in Retinal Diseases: From Off-Label Intravitreal Injection to Advanced Nano-Drug Delivery Systems
LA Aceves-Franco, OE Sanchez-Aguilar… - Biomedicines, 2023 - mdpi.com
Ophthalmic drug delivery to the posterior segment of the eye has been challenging due to
the complex ocular anatomy. Intravitreal injection of drugs was introduced to deliver …
the complex ocular anatomy. Intravitreal injection of drugs was introduced to deliver …
Commentary: Posterior subtenon triamcinolone-The unsung hero for managing various ocular disorders
K Tripathy - Indian Journal of Ophthalmology, 2023 - journals.lww.com
PST is usually given in the superotemporal quadrant by using a 26‑G needle in the Nozik
technique. Triamcinolone can be taken in a 2 mL (or 1 mL) syringe with a 25–27‑G needle …
technique. Triamcinolone can be taken in a 2 mL (or 1 mL) syringe with a 25–27‑G needle …
Switching to subtenon triamcinolone acetonide does not jeopardize the functional and anatomic outcomes of dexamethasone implant treated eyes with diabetic …
Y Borella, S Bertaud, R Tadayoni, B Bodaghi… - Graefe's Archive for …, 2024 - Springer
Background Intraocular dexamethasone implant (DEXi) is an efficient treatment for diabetic
macular edema (DME). However, it may be unavailable or contraindicated. Triamcinolone …
macular edema (DME). However, it may be unavailable or contraindicated. Triamcinolone …